Beone Medicines
ONC
Beone Medicines (ONC) analyst forecast and price target
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| Barclays | Maintained | Overweight | $407.00 from $403.00 | Aug 6, 2026 |
| Truist Securities | Maintained | Buy | $418.00 from $416.00 | Aug 6, 2026 |
| Guggenheim | Maintained | Buy | $430.00 from $420.00 | Aug 6, 2026 |
| Citizens | Maintained | Market Outperform | $405.00 from $396.00 | Aug 6, 2026 |
| RBC Capital | Maintained | Outperform | $450.00 from $451.00 | Aug 6, 2026 |
| TD Cowen | Maintained | Buy | $454.00 from $424.00 | Aug 6, 2026 |
| JP Morgan | Maintained | Overweight | $425.00 from $415.00 | Jul 23, 2026 |
| Barclays | Maintained | Overweight | $403.00 from $409.00 | Jul 14, 2026 |
| Jefferies | Upgraded | Hold → Buy | $380.00 from $333.00 | Jul 13, 2026 |
| Truist Securities | Maintained | Buy | $416.00 from $413.00 | Jul 7, 2026 |
| RBC Capital | Maintained | Outperform | $451.00 from $436.00 | Jul 7, 2026 |
| Citizens | Maintained | Market Outperform | $396.00 | Jul 1, 2026 |
| RBC Capital | Maintained | Outperform | $436.00 from $425.00 | Jun 2, 2026 |
| Leerink Partners | Maintained | Outperform | $367.00 from $364.00 | May 15, 2026 |
| Truist Securities | Maintained | Buy | $413.00 from $411.00 | May 7, 2026 |
| Barclays | Maintained | Overweight | $409.00 from $405.00 | May 7, 2026 |
| Guggenheim | Maintained | Buy | $420.00 from $410.00 | May 7, 2026 |
| RBC Capital | Maintained | Outperform | $425.00 from $423.00 | May 7, 2026 |
| Wells Fargo | Initiated Coverage | Overweight | $400.00 | May 4, 2026 |
| Wolfe Research | Initiated Coverage | Outperform | $340.00 | Mar 27, 2026 |
Frequently asked questions
What is the latest analyst rating on ONC?
On Aug 6, 2026, Barclays maintained Beone Medicines at Overweight with a price target of $407.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.